ConSynance Therapeutics is a company that provides Drug development, Steatohepatitis, Irritable bowel syndrome and more. ConSynance Therapeutics is headquartered in United States New York. ConSynance Therapeutics was founded in 2015. and was founded by Peter Guzzo, Peter Guzzo, Shuang Liu, Shuang Liu. ConSynance Therapeutics has a total of 5 patents
Related Topics
Drug developmentSteatohepatitisIrritable bowel syndromeDrug discoveryPharmacy and Therapeutics
What technical fields has ConSynance Therapeutics researched?
ConSynance Therapeutics has researched the technical fields related toDrug developmentSteatohepatitisIrritable bowel syndromeDrug discoveryPharmacy and Therapeutics
What is ConSynance Therapeutics's total number of patents?
ConSynance Therapeutics is a clinical-stage drug development company based in Rensselaer, New York. ConSynance’s pipeline includes innovative treatments...
What is ConSynance Therapeutics's official website?